Delivery Order SPE2DB25D3005-SPE2DB25FQGRD
- Not listed
- This is a $2,015.65 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication, with a period of performance through March 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order for COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,625.13 Firm Fixed Price contract is for the supply of COPAXONE 20 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a $1,638 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COPAXONE 40 MG/ML syringes, which are used to treat multiple sclerosis. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE. The $1,055.54 delivery order, which does not have a set-aside designation, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a...
- This is a $1,728.57 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide COPAXONE 40 MG/ML SYRINGE/ML. The award has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, with a particular focus on delivering a comprehensive range of pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,525.79 firm fixed-price delivery order is for COPAXONE 20 MG/ML SYRINGE, a multiple sclerosis medication. The contract has an ultimate completion date of June 17, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a $3,031.02 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Copaxone 40 mg/mL syringes, a medication used to treat multiple sclerosis. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,897.78, is for the delivery of COPAXONE 40 MG/ML syringes. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.00 firm fixed price delivery order is for the supply of COPAXONE 40 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQGRDDelivery Order
This is a $2,684.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COPAXONE 20 MG/ML SYRINGEML, a medication, with a period of performance through July 9, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract has no set-aside designation, indicating open competition. The award is associated with AmerisourceBergen Drug Corp's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 7/8/25 |